Invivyd · 1 day ago
Senior Director, Payer Access and Strategy
Invivyd, Inc. is dedicated to delivering protection from serious viral infectious diseases, focusing on immunocompromised individuals. The Senior Director, Payer Access and Strategy will lead market access strategies in the U.S., ensuring patient access to antibody-based therapies and collaborating across departments to drive launch success.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Develop and execute the U.S. Market Access strategy to support Invivyd’s commercial objectives and patient access goals
Build and lead a high-performing Market Access organization, encompassing National Accounts, Government Pricing & Contracting, Trade & Distribution, Managed Care, and Patient Services
Collaborate cross-functionally with Sales, Marketing, Medical Affairs, Finance, and Policy to align on pricing, reimbursement, and access strategies that drive launch success
Establish strong payer, channel, and institutional relationships to ensure optimal coverage and access across commercial and government segments
Monitor evolving U.S. payer dynamics, reimbursement trends, and healthcare policy changes to anticipate and address market access challenges
Serve as a key strategic advisor on corporate governance and commercial leadership forums regarding pricing, contracting, and value strategy
Ensure all Market Access programs, communications, and engagements adhere to the highest standards of compliance, integrity, and patient centricity
Qualification
Required
Bachelor's degree required
15–20+ years of U.S. Market Access experience with proven success leading access strategy and execution in specialty or biologic markets
Demonstrated expertise in payer strategy, reimbursement, pricing, contracting, and channel distribution
Strong understanding of the U.S. healthcare environment, including commercial, government, and integrated delivery network dynamics
Experience launching and managing specialty or infused/injectable biologics (mAbs strongly preferred)
Ability to thrive in a fast-paced, entrepreneurial environment, balancing strategic thinking with hands-on execution
Proven track record of building and mentoring high-performing, cross-functional teams
Excellent communication and influencing skills with internal stakeholders and external partners
Deep commitment to compliance, ethics, and patient-focused decision making
Preferred
Advanced degree (MBA, MPH, or equivalent) preferred
Company
Invivyd
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Funding
Current Stage
Public CompanyTotal Funding
$678.5MKey Investors
Silicon Valley BankRA Capital ManagementGoogle Ventures
2025-11-17Post Ipo Equity· $125M
2025-08-20Post Ipo Equity· $57.5M
2025-04-21Post Ipo Debt· $30M
Recent News
2025-12-24
2025-12-24
Company data provided by crunchbase